Phase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease

2008 ◽  
Vol 36 (6) ◽  
pp. 1323-1329 ◽  
Author(s):  
Zhi-Jian Yang ◽  
You-Rong Zhang ◽  
Bo Chen ◽  
Shu-Lan Zhang ◽  
En-Zhi Jia ◽  
...  
2014 ◽  
Vol 62 (S 01) ◽  
Author(s):  
A.-H. Dayeh ◽  
G. Taurosinov ◽  
J. El Bahi ◽  
D. Schranz ◽  
N. Evagelopoulos ◽  
...  

Medicina ◽  
2021 ◽  
Vol 57 (6) ◽  
pp. 595
Author(s):  
Mircea Bajdechi ◽  
Cosmin Mihai ◽  
Alexandru Scafa-Udriste ◽  
Ali Cherry ◽  
Diana Zamfir ◽  
...  

The pathophysiology of accelerated atherosclerosis in people living with Human Immunofediciency virus (HIV) is complex. Coronary artery disease (CAD) has become an important cause of mortality in these patients. They often have atypical symptoms, leading to frequently missed diagnoses. We report a case of a 51-year-old male undergoing antiretroviral therapy who was admitted for acute coronary syndrome. He had severe coronary artery disease that involved difficult management.


Sign in / Sign up

Export Citation Format

Share Document